Text Size

Glaucoma Research Foundation Celebrates 40 Year Anniversary

GRF Announces The Cure is in Sight Campaign Goal Extension during Annual Dinner and 40th Anniversary Celebration.

Glaucoma Research Foundation (GRF) hosted our 2018 Annual Dinner and 40th Anniversary celebration at the historic San Francisco War Memorial and Performing Arts Center Green Room on April 24th.

Welcoming more than 130 guests, GRF made the exciting announcement that The Cure is in Sight Campaign, which was publicly launched last year during the 2017 Annual Dinner, had surpassed its goal of $15 million. An extension of the capital campaign to raise $25 million by 2020 was announced at this year's event.

Martin Wax, MD presented his talk ‘Glaucoma Past, Present and Future’ as the centerpiece of the evening, taking guests through an informative history of glaucoma and GRF’s research progress. Dr. Wax highlighted GRF’s investment in the Catalyst for a Cure (CFC) collaborative research teams and the progress they have made toward a cure.

The first CFC team of four principal investigators, established in 2002, focused their research on neuroprotection and examined novel approaches to slowing the progression of glaucoma. The second team was formed in 2012, and were charged with identifying new glaucoma biomarkers to allow doctors to diagnose glaucoma earlier and treat it more effectively before vision is lost. The CFC Biomarker Initiative has now identified three promising new markers and are doing further testing and validation with patients.

Dr. Wax announced GRF’s plans to form a third collaborative team of investigators, who will focus their research on restoring vision lost from glaucoma. An impressive group of Scientific Advisors has been selected to oversee the program and identify the principal investigators. The CFC Vision Restoration Initiative will launch in January 2019.

GRF President and CEO, Thomas M. Brunner, proudly announced the success of The Cure is in Sight campaign by noting that the organization has reached and exceeded its ambitious goal of raising $15 million by June 2018, with $16.2 million raised to date. Mr. Brunner also announced that the campaign would continue until 2020 with a new goal of $25 million. The additional resources will allow for initial funding of the CFC Vision Restoration Initiative.

Mr. Brunner noted: “We are incredibly grateful to each and every one of our donors who have brought us to this critical point. This is the largest fundraising campaign in our history and we were overwhelmed with the support from donors around the world.”

“Our donors inspire our staff and researchers to continue our important mission to cure glaucoma and restore vision through innovative research. There’s not a moment to lose. Please know that we are resolute in our commitment toward a future free from glaucoma,” he added.

For more information about The Cure is in Sight Campaign, please visit www.glaucoma.org/campaign.

Last reviewed on September 10, 2018

This article appeared in the September 2018 issue of Gleams.


Was this helpful? Yes No